A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

Clinical trial NCT03786419 · WITHDRAWN

Trial details

NCT number: NCT03786419
Sponsor: Health Pharma Professional Research
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma, Advanced Malignant Pleural Mesothelioma, Unresectable

Start date: 2020-08-01
Primary completion: 2020-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.